Showing results (111-120 of 147) with videos related to
Sort By:
Pageof 15
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 26, 2008
Acute liver and renal failure during treatment with buprenorphine at therapeutic doseM Zuin, A Giorgini, C Selmi, et al.Medical Oncology (Northwood, London, England)|August 6, 2008
Efficacy of topotecan plus vincristine and doxorubicin in children with recurrent/refractory rhabdomyosarcomaC Meazza, M Casanova, E Zaffignani, et al.Hepato-Gastroenterology|December 5, 1998
Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled studyA Crosignani, G Budillon, L Cimino, et al.American Journal of Clinical Pathology|October 1, 1985
The significance of protein C antigen in acute and chronic liver biliary diseaseS Viganó, P M Mannucci, A D'Angelo, et al.The American Journal of Gastroenterology|February 18, 1999
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's diseaseA Tagger, M L Ribero, A Larghi, et al.Journal of Hepatology|November 1, 1993
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialS Bellentani, M Podda, C Tiribelli, et al.Hernia : the Journal of Hernias and Abdominal Wall Surgery|May 26, 2022
Laparoscopic approach in emergency for the treatment of acute incarcerated groin hernia: a systematic review and meta-analysisA Sartori, A Balla, E Botteri, et al.Hernia : the Journal of Hernias and Abdominal Wall Surgery|July 20, 2020
Should enhanced recovery after surgery (ERAS) pathways be preferred over standard practice for patients undergoing abdominal wall reconstruction? A systematic review and meta-analysisA Sartori, E Botteri, F Agresta, et al.The Italian Journal of Gastroenterology|November 1, 1992
Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trialP M Battezzati, M Podda, S Bruno, et al.Journal of Hepatology|July 4, 2001
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis CS Bruno, P M Battezzati, G Bellati, et al.Pageof 15